The UK Private GP EHR market is projected to grow due to increased patient care requirements and rising private GP service demand, as shown in a ResearchAndMarkets report. Factors such as GDPR, CQC regulations, reduced NHS GP numbers, and advancements in medical technology are anticipated to push this growth. However, cyber-attack risks and technical problems could hinder market expansion.
StockWatch: Price War Dampens Lilly Surge After Oral GLP-1 Wins FDA Nod
Eli Lilly (NYSE: LLY) won the approval it sought when the FDA authorized the company’s oral obesity drug Foundayo (orforglipron), but the pharma giant’s post-approval
